Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Avivagen Announces Closing of Private Placement of Debentures and Shares

Business Wire March 28, 2022

Avivagen Announces Proposed Private Placement of Debentures and Shares and Issuance of Shares in Lieu of Maintenance Fees

Business Wire March 23, 2022

Avivagen to Attend CEM Sponsored Alpha North Conference

Business Wire March 22, 2022

Avivagen Secures New Influential Customer in Mexico

Business Wire March 8, 2022

Avivagen Announces Approval in Vietnam

Business Wire February 22, 2022

Avivagen Announces CEO Update to Shareholders

Business Wire January 26, 2022

Avivagen Announces Appointment of James Nickerson as President

Business Wire January 25, 2022

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2021

Business Wire January 19, 2022

Avivagen Secures Large OxC-beta(TM) Livestock Order in Asia

Business Wire October 18, 2021

Avivagen to Hold Webcast to Discuss Landmark Deal with AB Vista

Business Wire October 4, 2021

AB Vista and Avivagen Strike OxC-beta(TM) Supply Agreement in the United States, Brazil and Thailand

Business Wire October 1, 2021

Avivagen Provides Further Detail on its Third Quarter Results Ending July 31, 2021

Business Wire September 30, 2021

Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2021

Business Wire September 29, 2021

Avivagen Announces Strategic Changes to Support Growth in Asia and South America

Business Wire July 22, 2021

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

Business Wire June 11, 2021

Avivagen to Present at LD Micro Conference Presentation on June 10th, at 10:30 A.M. EST

Business Wire June 8, 2021

Avivagen Inc. Announces Proposed Extension of Warrants and Grant of Options

Business Wire June 7, 2021

Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2021

Business Wire June 2, 2021

Avivagen Terminates Exclusive U.S. Sales and Distribution Agreement

Business Wire May 7, 2021

Avivagen Continues Market Growth with New Customer Win in Western Mexico

Business Wire May 6, 2021